Archives

Pegrizeprument Granted Orphan Drug Designation for Prevention of Organ Rejection in Heart Transplant Patients

B CARY, N.C., April 22, 2026 /PRNewswire/ — Veloxis Pharmaceuticals, Inc. (Veloxis), a global specialty pharmaceutical company part of Asahi Kasei Corporation, announced today that pegrizeprument… Login to continue reading Login…

Read MorePegrizeprument Granted Orphan Drug Designation for Prevention of Organ Rejection in Heart Transplant Patients

Chico’s FAS Unveils First-Ever Credit Card Program and Reimagined Loyalty Experience Across Chico’s, Soma, and White House Black Market in partnership with Synchrony and Mastercard

B Updated Loyalty Programs Introduce First-Ever Credit Cards for the Brands, Offering Enhanced Rewards and Expanded Payment Options Key Highlights: Chico’s FAS and Synchrony have… Login to continue reading Login…

Read MoreChico’s FAS Unveils First-Ever Credit Card Program and Reimagined Loyalty Experience Across Chico’s, Soma, and White House Black Market in partnership with Synchrony and Mastercard

Evergreen Nephrology and Partners Demonstrate Strong Patient Outcomes and Cost Savings in Medicare’s 2024 Kidney Care Choices Program

B Over $40 million in Medicare savings emphasizes Evergreen’s role in improving care for patients with advanced kidney disease NASHVILLE, Tenn., April 22, 2026 /PRNewswire/… Login to continue reading Login…

Read MoreEvergreen Nephrology and Partners Demonstrate Strong Patient Outcomes and Cost Savings in Medicare’s 2024 Kidney Care Choices Program